Harvard Bioscience Inc (NASDAQ:HBIO)
| 3.06 Delayed Data As of 3:59pm ET |  -0.05 / -1.61%Today’s Change | 1.98 Today|||52-Week Range 6.49 | +10.47% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $124.6M |
Company Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
Contact Information
Harvard Bioscience, Inc. 84 October Hill Road Holliston Massachusetts 01746-1371 |
Employees
Shareholders
| Other institutional | 52.73% |
| Individual stakeholders | 29.94% |
| Mutual fund holders | 18.06% |
Top Executives
| James W. Green | Chairman, President & Chief Executive Officer |
| Jennifer Cote | Chief Financial Officer & Treasurer |
| Ryan Wallace | Vice President-Global Sales, Preclinical Systems |
| Jacques Coumans | Chief Marketing Officer |
| John J. Fry | Secretary & Chief Legal Counsel |
